Streptomyces sennicomposti GMY01 extract induces apoptosis and cell cycle arrest in T47D breast cancer cells
Journal of Pharmacy & Pharmacognosy Research · 01.03.2026 · 14 (2) · 2111
DOI: 10.56499/jppres_14.2.2111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmacognosy Research, online erschienen am 01.03.2026. Verfasst von Rizza U. Nuzulia und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Context
Streptomyces spp. produces diverse anticancer secondary metabolites. Strain GMY01, isolated from marine sediment, exhibits cytotoxicity against multiple cancer cell lines. Despite that, the anticancer mechanism, especially in breast cancer cell lines T47D, resulting from the ethyl acetate extract of S. sennicomposti strain GMY01, remains unclear.
Aims
To elucidate the anticancer mechanism of ethyl‐acetate extracts of GMY01 in T47D breast cancer cells.
Methods
Secondary metabolites were obtained from 11‐day Starch Nitrate Broth (SNB) fermentation, extracted with ethyl acetate, and profiled by LC‐MS/MS. Cytotoxicity (MTT), apoptosis, and cell‐cycle distribution were assessed by flow cytometry. Also, the selectivity index (SI) and IC50 were calculated.
Results
The GMY01 ethyl acetate extract exhibited potent cytotoxicity against T47D cells (IC50 = 12.72 ± 3.78 μg/mL; SI = 26.95) and significantly induced cell death and apoptosis. At IC50, late and early apoptosis increased to 13.95% and 16.25%, respectively, and cell‐cycle arrest occurred in S/G₂M-phases. At half the IC50 (6.36 μg/mL), the extract significantly induced cell death via early apoptosis only. LC‐MS/MS identified propoxur, isobutyranilide, dibenzylacetone, amantadine, and mitomycin G.
Conclusions
GMY01 ethyl‐acetate extract induces apoptosis and cell‐cycle arrest in T47D cells, with mitomycin G likely a key active compound. These results indicate that GMY01 extract has potential as a lead for anticancer drug development. The ethyl acetate extract of GMY01 exhibited strong cytotoxicity against T47D cells and induced apoptosis, suggesting its potential as an anticancer agent. However, this research still requires further investigation.
Zitieren
APA
Nuzulia, R. U., Damayanti, E., Sunaryanto, R., Pasala, M., Widada, J., & Mustofa, M. (2026). Streptomyces sennicomposti GMY01 extract induces apoptosis and cell cycle arrest in T47D breast cancer cells. Journal of Pharmacy & Pharmacognosy Research, 14(2), 2111. https://doi.org/10.56499/jppres_14.2.2111
Vancouver
Nuzulia RU, Damayanti E, Sunaryanto R, Pasala M, Widada J, Mustofa M. Streptomyces sennicomposti GMY01 extract induces apoptosis and cell cycle arrest in T47D breast cancer cells. Journal of Pharmacy & Pharmacognosy Research. 2026;14(2):2111. doi:10.56499/jppres_14.2.2111
BibTeX
@article{Nuzulia2026,
author = {Nuzulia, Rizza U. and Damayanti, Ema and Sunaryanto, Rofiq and Pasala, Metamalik and Widada, Jaka and Mustofa, Mustofa},
title = {Streptomyces sennicomposti GMY01 extract induces apoptosis and cell cycle arrest in T47D breast cancer cells},
journal = {Journal of Pharmacy & Pharmacognosy Research},
year = {2026},
volume = {14},
number = {2},
pages = {2111},
doi = {10.56499/jppres_14.2.2111}
}
EUVIMED